Press Releases

Feb 20, 2024
BASKING RIDGE, N.J., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, today announced that David J.
Jan 17, 2024
Lisata Therapeutics to Present at the Sequire Investor Summit in Puerto Rico BASKING RIDGE, NJ (January 18, 2024)  – Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid
Displaying 11 - 14 of 14